dc.contributor.author | Galaup, Ariane | - |
dc.contributor.author | Germain, Stéphane | - |
dc.date.accessioned | 2014-08-13T07:19:54Z | |
dc.date.available | 2014-08-13T07:19:54Z | |
dc.date.issued | 2008 | fr_FR |
dc.identifier.citation | Galaup, Ariane ; Germain, Stéphane ; Les anticorps anti-PlGF, Med Sci (Paris), 2008, Vol. 24, N° 5; p. 459-462 ; DOI : 10.1051/medsci/2008245459 | fr_FR |
dc.identifier.issn | 1958-5381 | fr_FR |
dc.identifier.uri | http://hdl.handle.net/10608/6443 | |
dc.language.iso | fr | fr_FR |
dc.publisher | EDK | fr_FR |
dc.relation.ispartof | Le Magazine : Nouvelles | fr_FR |
dc.rights | Article en libre accès | fr |
dc.rights | Médecine/Sciences - Inserm - SRMS | fr |
dc.source | M/S. Médecine sciences [ISSN papier : 0767-0974 ; ISSN numérique : 1958-5381], 2008, Vol. 24, N° 5; p. 459-462 | fr_FR |
dc.title | Les anticorps anti-PlGF : Un nouvel outil thérapeutique anti-angiogénique ? | fr |
dc.title.alternative | Blocking PlGF, a future in anti-angiogenic therapy ? | en |
dc.type | Article | fr_FR |
dc.contributor.affiliation | IFOM-IEO, Laboratoire « New strategies to inhibit tumor angiogenesis», IFOM-IEO Campus, Via Adamello, 16 20139 Milan, Italie | fr_FR |
dc.contributor.affiliation | Collège de France, Chaire de Médecine Expérimentale, Paris, France | fr_FR |
dc.contributor.affiliation | Inserm U833, Paris, France | fr_FR |
dc.contributor.affiliation | Service d’Hématologie Biologique A, AP-HP, Hôpital Européen Georges Pompidou, Paris, France | fr_FR |
dc.identifier.doi | 10.1051/medsci/2008245459 | fr_FR |
dc.identifier.pmid | 18466718 | fr_FR |